MD Anderson and Hitachi to collaborate in research for treatment of oropharyngeal cancer of the head and neck

(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Hitachi Healthcare Americas Corporation, have today announced that they have entered into an agreement to collaborate on research for a unique randomized clinical trial comparing the outcomes and side-effects of intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of oropharyngeal cancer of the head and neck.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news